Similar articles

• Quality of life evaluations in patients with ovarian cancer during chemotherapy treatment.

  Le T, Leis A, Pahwa P, Wright K, Ali K, Reeder B, Hopkins L, Fung MF. Le T, et al. Gynecol Oncol. 2004 Mar;92(3):839-44. doi: 10.1016/j.ygyno.2003.11.034. Gynecol Oncol. 2004. PMID: 14984950
• Survivorship issues in ovarian cancer: a review.

  Lockwood-Rayermann S. Lockwood-Rayermann S. Oncol Nurs Forum. 2006 May 3;33(3):553-62. doi: 10.1188/06.ONF.553-562. Oncol Nurs Forum. 2006. PMID: 16676012 Review.
• Quality of life of Chinese patients with ovarian malignancies during chemotherapy under condition of no recurrence.

  Ding Y, Zhu YL, Zhang MF. Ding Y, et al. Cancer Nurs. 2007 May-Jun;30(3):243-51. doi: 10.1097/01.NCC.0000270703.57166.e2. Cancer Nurs. 2007. PMID: 17510589
• The prognostic effects of performance status and quality of life scores on progression-free survival and overall survival in advanced ovarian cancer.

  Carey MS, Bacon M, Tu D, Butler L, Bezjak A, Stuart GC. Carey MS, et al. Gynecol Oncol. 2008 Jan;108(1):100-5. doi: 10.1016/j.ygyno.2007.08.088. Epub 2007 Oct 24. Gynecol Oncol. 2008. PMID: 17920108 Clinical Trial.
• Intraperitoneal chemotherapy for women with epithelial ovarian cancer.

  Trimble EL, Thompson S, Christian MC, Minasian L. Trimble EL, et al. Oncologist. 2008 Apr;13(4):403-9. doi: 10.1634/theoncologist.2007-0058. Oncologist. 2008. PMID: 18448554 Review.